Cui S. et al.
Editor's note
The other Cochrane verdict — in vascular dementia, IV cerebrolysin courses improved cognition and global function with no adverse-event signal. A friendlier read than the stroke review; sample sizes still modest and follow-up short.
Related literature
Ziganshina L.E., Abakumova T., Hoyle C.H.V.
The Cochrane review that keeps deflating the cerebrolysin story. Across pooled RCTs in acute ischemic stroke, no convincing effect on death or dependency. If you read one paper on cerebrolysin and stroke, read this one — and notice the gap between Cochrane's read and the marketing.
Muresanu D.F. et al.
Multidimensional ensemble of outcomes in moderate-severe TBI; modest but consistent benefit on the composite endpoint at 90 days. Methodologically unusual primary analysis — the authors essentially pooled scales to get power. Read as suggestive, not definitive.
Poon W. et al.
CAPTAIN I — the Asian-Pacific companion to CAPTAIN II in moderate-to-severe TBI. Similar multidimensional analytic approach, similar directional benefit, similar sample-size limitation. Take the two CAPTAIN trials together as the modern cerebrolysin TBI dataset.
Medvedeva E.V. et al.
One of the few semax papers in an indexed English-language journal. Rat focal-ischemia model with a respectable transcriptomic readout — immune and vascular gene programs shift. Preclinical only; the Russian clinical literature on semax has not been replicated in Western trials.
001 — Independent
SavePeptides lists vendors after an initial review and distinguishes verified vendors where additional checks have been completed. We may earn commissions from referral links, and sponsored placements will be clearly disclosed.
002 — Vendor-funded
SavePeptides is free for buyers. We may earn a commission when you order through our links, but we do not lock deals behind a paywall, require an email to view codes, or inflate comparison prices.
003 — Research use
SavePeptides surfaces vendor, pricing, and coupon information for research compounds. These products are not intended, approved, or recommended for human consumption. Our content is informational only and does not constitute medical advice.